To estimate the effect of second-line panitumumab monotherapy on objective response rate in patients with metastatic or recurrent squamous cell carcinoma of the head and neck 70 days [clinicaltrials_resource:1b25d3b058a475a5372571f5fe99ccfd]
Single Arm Monotherapy Study
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
To estimate the effect of second-line panitumumab monotherapy on objective response rate in patients with metastatic or recurrent squamous cell carcinoma of the head and neck 70 days [clinicaltrials_resource:1b25d3b058a475a5372571f5fe99ccfd]
Single Arm Monotherapy Study
Bio2RDF identifier
1b25d3b058a475a5372571f5fe99ccfd
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1b25d3b058a475a5372571f5fe99ccfd
measure [clinicaltrials_vocabulary:measure]
To estimate the effect of seco ...... carcinoma of the head and neck
time frame [clinicaltrials_vocabulary:time-frame]
description
Single Arm Monotherapy Study
identifier
clinicaltrials_resource:1b25d3b058a475a5372571f5fe99ccfd
title
To estimate the effect of seco ...... a of the head and neck 70 days
@en
type
label
To estimate the effect of seco ...... 5d3b058a475a5372571f5fe99ccfd]
@en